posted on 2023-12-07, 17:37authored byZhengxin Yu, Glenn Blade, Bailey S. Bouley, Iwona T. Dobrucki, Lawrence W. Dobrucki, Liviu M. Mirica
The broader utilization of 64Cu positron emission
tomography
(PET) imaging agents has been hindered by the unproductive demetalation
induced by bioreductants. To advance the development of 64Cu-based PET imaging tracers for Alzheimer’s Disease (AD),
there is a need for novel ligand design strategies. In this study,
we developed sulfur-containing dithiapyridinophane (N2S2) bifunctional
chelators (BFCs) as well as all nitrogen-based diazapyridinophane
(N4) BFCs to compare their abilities to chelate Cu and target Aβ
aggregates. Through spectrophotometric titrations and electrochemical
measurements, we have demonstrated that the N2S2-based BFCs exhibit
>10 orders of magnitude higher binding affinity toward Cu(I) compared
to their N4-based counterparts, while both types of BFCs exhibit high
stability constants toward Cu(II). Notably, solid state structures
for both Cu(II) and Cu(I) complexes supported by the two ligand frameworks
were obtained, providing molecular insights into their copper chelating
abilities. Aβ binding experiments were conducted to study the
structure–affinity relationship, and fluorescence microscopy
imaging studies confirmed the selective labeling of the BFCs and their
copper complexes. Furthermore, we investigated the potential of these
ligands for the 64Cu-based PET imaging of AD through radiolabeling
and autoradiography studies. We believe our findings provide molecular
insights into the design of bifunctional Cu chelators that can effectively
stabilize both Cu(II) and Cu(I) and, thus, can have significant implications
for the development of 64Cu PET imaging as a diagnostic
tool for AD.